Co-founder and Chief Science Officer – Levolta Pharmaceuticals
Renee Stewart is Co-founder and Chief Science Officer of Levolta Pharmaceuticals. At Levolta, Renee oversees the pre-clinical small molecule program. As Co-founder, she also does investor and strategic engagement in the Philadelphia area as the company seeks partners for developing its first-in-class, disease modifying treatment for osteoarthritis.
Renee’s background includes a PhD in Cell and Molecular Biology and work with viruses such as adenovirus, flu, and SV40. With husband business partner, she helped establish and was CEO of IMC Biotechnology, a company with early stage pre-clinical assets for autoimmune diseases.
Renee is former Chair of the Philadelphia Metro Chapter of Women in Bio. She is currently empty nesting with her husband in the Lehigh Valley.